BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15797865)

  • 1. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers.
    Zheng H; Kiss RS; Franklin V; Wang MD; Haidar B; Marcel YL
    J Biol Chem; 2005 Jun; 280(22):21612-21. PubMed ID: 15797865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.
    Kiss RS; McManus DC; Franklin V; Tan WL; McKenzie A; Chimini G; Marcel YL
    J Biol Chem; 2003 Mar; 278(12):10119-27. PubMed ID: 12547832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.
    Maric J; Kiss RS; Franklin V; Marcel YL
    J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages.
    Wang MD; Franklin V; Sundaram M; Kiss RS; Ho K; Gallant M; Marcel YL
    J Biol Chem; 2007 Aug; 282(31):22525-33. PubMed ID: 17553802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.
    Ji A; Wroblewski JM; Webb NR; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1910-6. PubMed ID: 25060793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.
    Yue P; Chen Z; Nassir F; Bernal-Mizrachi C; Finck B; Azhar S; Abumrad NA
    PLoS One; 2010 Mar; 5(3):e9906. PubMed ID: 20360851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1).
    Denis M; Haidar B; Marcil M; Bouvier M; Krimbou L; Genest J
    J Biol Chem; 2004 Feb; 279(9):7384-94. PubMed ID: 14660648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells.
    Zhang LH; Kamanna VS; Ganji SH; Xiong XM; Kashyap ML
    J Lipid Res; 2012 May; 53(5):941-950. PubMed ID: 22389325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
    Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA
    J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes.
    Liu W; Qin L; Yu H; Lv F; Wang Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):614-22. PubMed ID: 24219083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein.
    Abe-Dohmae S; Ikeda Y; Matsuo M; Hayashi M; Okuhira K; Ueda K; Yokoyama S
    J Biol Chem; 2004 Jan; 279(1):604-11. PubMed ID: 14570867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway.
    Tsujita M; Wu CA; Abe-Dohmae S; Usui S; Okazaki M; Yokoyama S
    J Lipid Res; 2005 Jan; 46(1):154-62. PubMed ID: 15520446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
    Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte modulation of high-density lipoprotein cholesterol.
    Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
    Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.
    Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA
    FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
    Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
    J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.